QGEN - Company ID 0001015820
QIAGEN N.V. (QGEN) reported revenue of $2.09B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $2.09B | +5.7% |
| FY 2024 | $1.98B | +0.7% |
| FY 2023 | $1.97B | -8.2% |
| FY 2022 | $2.14B | -4.9% |
| FY 2021 | $2.25B | +20.4% |
| FY 2020 | $1.87B | +22.5% |
| FY 2019 | $1.53B | +1.6% |
| FY 2018 | $1.50B | +5.9% |
| FY 2017 |
QIAGEN N.V. (QGEN) reported revenue of $2.09B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, QIAGEN N.V.'s revenue grew from $1.17B to $2.09B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.42B |
| +5.9% |
| FY 2016 | $1.34B | +4.5% |
| FY 2015 | $1.28B | -4.7% |
| FY 2014 | $1.34B | +3.3% |
| FY 2013 | $1.30B | +3.8% |
| FY 2012 | $1.25B | +7.2% |
| FY 2011 | $1.17B | - |